Global Pen Needles Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Pen Needles Market is presumed to reach the market size of nearly USD 5.59 BN by 2030 from USD 2.19 BN in 2022 with a CAGR of 12.4% under the study period 2023 - 2030.

Pen needles are small, disposable medical devices used for injecting insulin into the subcutaneous tissue for the management of diabetes. They are specifically designed for use with insulin pens, which are popular devices for administering insulin. It consists of a thin, hollow needle attached to a plastic hub, which connects to the insulin pen. They come in various lengths and gauges to accommodate different patient needs.

MARKET DYNAMICS:

The rising prevalence of diabetes worldwide is a significant driver, as more individuals are diagnosed with the condition and require insulin delivery systems. Pen needles offer a convenient and accurate method for insulin administration, catering to the needs of diabetic patients. The increasing adoption of insulin pens is another driving factor. Insulin pens have become popular due to their ease of use, portability, and discreetness. Pen needles are specifically designed for insulin pens, and as their adoption increases, so does the demand for these needles. Advancements in its technology play a vital role in market growth. Manufacturers are continuously improving designs to enhance patient comfort with features like ultra-thin needles, lubricated surfaces, and improved needle-tip geometries. These innovations aim to minimise pain and provide a better overall insulin injection experience. Patient preference for self-administration of insulin injections is increasing, contributing to the demand for these products. Many individuals with diabetes prefer to have more control over their treatment and rely less on healthcare professionals. Pen needles offer a user-friendly and convenient option for self-administration, supporting patients' desire for independence in their diabetes care. Government initiatives and support in diabetes management also drive the market. Governments and healthcare organisations are actively promoting awareness, early diagnosis, and treatment options for diabetes, which in turn increases the demand for pen needles as an essential component of insulin therapy.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pen needles. The growth and trends of pen needles industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the pen needles market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Standard Pen Needles
Safety Pen Needles

By Length

4Mm
5Mm
6Mm
8Mm
10Mm
12Mm

By Therapy

Insulin Therapy
Glucagon-Like Peptide-1 (GLP-1) Therapy
Growth Hormone Therapy
Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Pen Needles market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pen needles market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), HTL-STREFA (Poland), UltiMed (US), Artsana Group (Italy), Allison Medical (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

Product Code: VMR112111528

1 . PREFACE

1.1. Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PEN NEEDLES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Length
- 3.7.3 Market Attractiveness Analysis By Therapy
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Standard Pen Needles Historic and Forecast Sales by Regions
5.5 Safety Pen Needles Historic and Forecast Sales by Regions

6 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY LENGTH

6.1 Overview by Length
6.2 Historical and Forecast Data
6.3 Analysis by Length
6.4 4mm Historic and Forecast Sales by Regions
6.5 5mm Historic and Forecast Sales by Regions
6.6 6mm Historic and Forecast Sales by Regions
6.7 8mm Historic and Forecast Sales by Regions
6.8 10mm Historic and Forecast Sales by Regions
6.9 12mm Historic and Forecast Sales by Regions

7 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY THERAPY

7.1 Overview by Therapy
7.2 Historical and Forecast Data
7.3 Analysis by Therapy
7.4 Insulin Therapy Historic and Forecast Sales by Regions
7.5 Glucagon-like Peptide-1 (GLP-1) Therapy Historic and Forecast Sales by Regions
7.6 Growth Hormone Therapy Historic and Forecast Sales by Regions
7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PEN NEEDLES COMPANIES

9.1. Pen Needles Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PEN NEEDLES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Becton
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Dickinson and Company (US)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Novo Nordisk A/S (Denmark)
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Ypsomed Holding AG (Switzerland)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. B. Braun Melsungen AG (Germany)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Owen Mumford (UK)
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Terumo Corporation (Japan)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. HTL-STREFA (Poland)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. UltiMed (US)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Artsana Group (Italy)
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Allison Medical (US)
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies